InMed Pharmaceuticals Inc. (INM) is the 293rd largest of 300 Specialty Chemicals companies by market capitalisation, at 5.26 Mn, behind Gulf Resources, Inc. at 5.35 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GLW | Corning Inc /Ny | primary | M-02 | Chemicals | MG-01 | 145.13 Bn | 69.97 | 8.55 | 142.62 Bn |
| 2 | ATI | Ati Inc | primary | M-02 | Chemicals | MG-01 | 28.63 Bn | 58.57 | 6.07 | 27.85 Bn |
| 3 | Q | Qnity Electronics, Inc. | primary | M-02 | Chemicals | MG-01 | 26.09 Bn | 42.98 | 5.01 | 25.13 Bn |
| 4 | IFF | International Flavors & Fragrances Inc | primary | M-02 | Chemicals | MG-01 | 21.51 Bn | 73.66 | 2.16 | 20.94 Bn |
| 5 | DD | DuPont de Nemours, Inc. | primary | M-02 | Chemicals | MG-01 | 17.57 Bn | 94.96 | 2.51 | 15.83 Bn |
| 6 | AVY | Avery Dennison Corp | primary | M-02 | Chemicals | MG-01 | 12.97 Bn | 18.40 | 1.40 | 12.74 Bn |
| 7 | ESI | Element Solutions Inc | primary | M-02 | Chemicals | MG-01 | 8.80 Bn | 49.22 | 2.79 | 8.61 Bn |
| 8 | EMN | Eastman Chemical Co | primary | M-02 | Chemicals | MG-01 | 7.86 Bn | 11.77 | 0.89 | 7.17 Bn |
| 9 | HXL | Hexcel Corp /De/ | primary | M-02 | Chemicals | MG-01 | 6.87 Bn | 44.77 | 3.47 | 6.81 Bn |
| 10 | SXT | Sensient Technologies Corp | primary | M-02 | Chemicals | MG-01 | 5.60 Bn | 36.08 | 3.29 | 5.57 Bn |
| 11 | BCPC | Balchem Corp | primary | M-02 | Chemicals | MG-01 | 5.42 Bn | 32.98 | 4.99 | 5.36 Bn |
| 12 | CLMT | Calumet, Inc. /DE | primary | M-02 | Chemicals | MG-01 | 4.77 Bn | -34.90 | 1.04 | 4.62 Bn |
| 13 | CBT | Cabot Corp | primary | M-02 | Chemicals | MG-01 | 4.12 Bn | 18.64 | 1.13 | 3.87 Bn |
| 14 | ASH | Ashland Inc. | primary | M-02 | Chemicals | MG-01 | 3.30 Bn | 14.36 | 1.79 | 2.86 Bn |
| 15 | KWR | Quaker Chemical Corp | primary | M-02 | Chemicals | MG-01 | 2.69 Bn | 33.37 | 1.36 | 2.53 Bn |
| 16 | HWKN | Hawkins Inc | primary | M-02 | Chemicals | MG-01 | 2.57 Bn | 31.91 | 2.33 | 2.56 Bn |
| 17 | NGVT | Ingevity Corp | primary | M-02 | Chemicals | MG-01 | 2.37 Bn | 43.89 | 2.04 | 2.19 Bn |
| 18 | ROG | Rogers Corp | primary | M-02 | Chemicals | MG-01 | 2.31 Bn | 73.84 | 2.77 | 2.10 Bn |
| 19 | IOSP | Innospec Inc. | primary | M-02 | Chemicals | MG-01 | 2.30 Bn | 20.07 | 1.25 | 2.05 Bn |
| 20 | SCL | Stepan Co | primary | M-02 | Chemicals | MG-01 | 1.42 Bn | -3,226.66 | 0.58 | 1.31 Bn |
| 21 | FTK | Flotek Industries Inc/Cn/ | primary | M-02 | Chemicals | MG-01 | 0.96 Bn | 25.18 | 3.27 | 0.95 Bn |
| 22 | KOP | Koppers Holdings Inc. | primary | M-02 | Chemicals | MG-01 | 0.88 Bn | -10.15 | 0.47 | 0.84 Bn |
| 23 | LWLG | Lightwave Logic, Inc. | primary | M-02 | Chemicals | MG-01 | 0.83 Bn | -65.48 | 5,683.13 | 0.83 Bn |
| 24 | MATV | Mativ Holdings, Inc. | primary | M-02 | Chemicals | MG-01 | 0.70 Bn | 7.77 | 0.35 | 0.62 Bn |
| 25 | RYAM | Rayonier Advanced Materials Inc. | primary | M-02 | Chemicals | MG-01 | 0.57 Bn | -4.22 | 0.39 | 0.51 Bn |
| 26 | ASPI | ASP Isotopes Inc. | primary | M-02 | Chemicals | MG-01 | 0.48 Bn | -3.22 | 15.53 | 0.22 Bn |
| 27 | MAGN | Magnera Corp | primary | M-02 | Chemicals | MG-01 | 0.41 Bn | -4.88 | 0.12 | 0.13 Bn |
| 28 | ASPN | Aspen Aerogels Inc | primary | M-02 | Chemicals | MG-01 | 0.40 Bn | -8.99 | 1.99 | 0.25 Bn |
| 29 | OEC | Orion S.A. | primary | M-02 | Chemicals | MG-01 | 0.32 Bn | -3.35 | 0.18 | 0.27 Bn |
| 30 | ALTO | Alto Ingredients, Inc. | primary | M-02 | Chemicals | MG-01 | 0.30 Bn | 5.92 | 0.32 | 0.27 Bn |
| 31 | FF | FutureFuel Corp. | primary | M-02 | Chemicals | MG-01 | 0.24 Bn | -8.12 | 1.53 | 0.20 Bn |
| 32 | HDSN | Hudson Technologies Inc /Ny | primary | M-02 | Chemicals | MG-01 | 0.22 Bn | 24.91 | 0.87 | 0.20 Bn |
| 33 | ACNT | Ascent Industries Co. | primary | M-02 | Chemicals | MG-01 | 0.14 Bn | -30.63 | 1.63 | 0.11 Bn |
| 34 | CITR | CitroTech Inc. | primary | M-02 | Chemicals | MG-01 | 0.11 Bn | -3.46 | 82.19 | 0.11 Bn |
| 35 | ARQ | Arq, Inc. | primary | M-02 | Chemicals | MG-01 | 0.09 Bn | -1.74 | 0.74 | 0.09 Bn |
| 36 | KBLB | Kraig Biocraft Laboratories, Inc. | primary | M-02 | Chemicals | MG-01 | 0.09 Bn | -22.61 | — | 0.09 Bn |
| 37 | NTIC | Northern Technologies International Corp | primary | M-02 | Chemicals | MG-01 | 0.07 Bn | -958.08 | 0.81 | 0.07 Bn |
| 38 | ZTEK | Zentek Ltd. | primary | M-02 | Chemicals | MG-01 | 0.06 Bn | -11.95 | 256.85 | 0.05 Bn |
| 39 | EXOZ | Exozymes Inc. | primary | M-02 | Chemicals | MG-01 | 0.05 Bn | -5.30 | — | 0.05 Bn |
| 40 | SCIA | SCI Engineered Materials, Inc. | primary | M-02 | Chemicals | MG-01 | 0.04 Bn | 15.59 | 1.40 | 0.03 Bn |
| 41 | NNUP | Nocopi Technologies Inc/Md/ | primary | M-02 | Chemicals | MG-01 | 0.02 Bn | -33.65 | 10.54 | 0.02 Bn |
| 42 | INM | InMed Pharmaceuticals Inc. | primary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.66 | — | 0.00 Bn |
| 43 | BON | Bon Natural Life Ltd | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | -1.52 | 0.49 | -0.02 Bn |
| 44 | SMTK | SmartKem, Inc. | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 45 | TSEOQ | Trinseo PLC | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | 0.00 | 0.00 | -0.18 Bn |
| 46 | CNEY | Cn Energy Group. Inc. | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | -0.02 | 0.01 | -0.02 Bn |
| 47 | TANH | Tantech Holdings Ltd | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | -0.01 | 0.00 | -0.03 Bn |
| 48 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 647.54 Bn | 30.78 | 6.61 | 626.78 Bn |
| 49 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 441.45 Bn | 69.89 | 6.86 | 434.88 Bn |
| 50 | CVX | Chevron Corp | secondary | E-01 | Oil and Gas Upstream | EG-01 | 419.57 Bn | 20.07 | 1.95 | 411.04 Bn |
| 51 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.78 Bn | 115.11 | 5.48 | 357.64 Bn |
| 52 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 267.01 Bn | 9.27 | 3.89 | 259.32 Bn |
| 53 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.55 Bn | -62.71 | 5.96 | 178.37 Bn |
| 54 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.95 Bn | 36.39 | 2.50 | 147.25 Bn |
| 55 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.31 Bn | 30.03 | 10.51 | 124.45 Bn |
| 56 | PSX | Phillips 66 | secondary | E-01 | Oil and Gas Upstream | EG-01 | 104.41 Bn | 14.52 | 0.67 | 100.31 Bn |
| 57 | SHW | Sherwin Williams Co | secondary | M-03 | Chemicals | MG-01 | 78.07 Bn | 29.04 | 3.20 | 77.77 Bn |
| 58 | ECL | Ecolab Inc. | secondary | I-38 | Environmental Equipment | IG-09 | 76.71 Bn | 37.36 | 4.55 | 71.58 Bn |
| 59 | HON | Honeywell International Inc | secondary | I-01 | Aerospace and Defense | IG-01 | 65.41 Bn | 8.05 | 1.72 | 56.21 Bn |
| 60 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.54 Bn | 11.27 | 0.98 | 45.16 Bn |
| 61 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.23 Bn | -25.01 | — | 44.23 Bn |
| 62 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.93 Bn | 61.68 | 2.48 | 39.28 Bn |
| 63 | LYB | LyondellBasell Industries N.V. | secondary | M-01 | Chemicals | MG-01 | 41.67 Bn | -120.79 | 1.34 | 39.04 Bn |
| 64 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.97 Bn | 52.83 | 3.16 | 32.51 Bn |
| 65 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.10 Bn | -20.28 | 2,755.62 | 30.10 Bn |
| 66 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.92 Bn | 14.59 | 1.41 | 27.81 Bn |
| 67 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.83 Bn | -31.80 | 24.46 | 26.67 Bn |
| 68 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.36 Bn | 15.73 | 4.36 | 20.82 Bn |
| 69 | PPG | Ppg Industries Inc | secondary | M-03 | Chemicals | MG-01 | 23.97 Bn | 15.16 | 1.46 | 22.38 Bn |
| 70 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.31 Bn | 16.26 | 6.76 | 18.65 Bn |
| 71 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.25 Bn | -46.86 | 1.31 | 18.36 Bn |
| 72 | MKSI | Mks Inc | secondary | T-03 | Semiconductors | TG-01 | 18.04 Bn | 73.95 | 4.15 | 17.43 Bn |
| 73 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.53 Bn | 22.02 | 4.60 | 15.15 Bn |
| 74 | FN | Fabrinet | secondary | T-14 | Computer Hardware | TG-02 | 15.17 Bn | 32.08 | 3.27 | 14.30 Bn |
| 75 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.13 Bn | 16.08 | 3.29 | 13.51 Bn |
| 76 | ALB | Albemarle Corp | secondary | M-11 | Metals and Mining | MG-02 | 14.72 Bn | 71.02 | 2.49 | 13.09 Bn |
| 77 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.48 Bn | 40.67 | 4.12 | 13.88 Bn |
| 78 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.41 Bn | 16.75 | 5.92 | 13.57 Bn |
| 79 | RPM | Rpm International Inc/De/ | secondary | M-03 | Chemicals | MG-01 | 12.75 Bn | 19.24 | 1.62 | 12.43 Bn |
| 80 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.29 Bn | 226.82 | 14.80 | 11.99 Bn |
| 81 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.40 Bn | -38.04 | 108.54 | 10.71 Bn |
| 82 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.88 Bn | -70.79 | 14.01 | 10.56 Bn |
| 83 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.68 Bn | -67.82 | 17.43 | 10.57 Bn |
| 84 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.20 Bn | -26.74 | — | 9.44 Bn |
| 85 | AVTR | Avantor, Inc. | secondary | I-31 | Distribution and Rental | IG-07 | 10.09 Bn | -17.46 | 1.54 | 9.79 Bn |
| 86 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 87 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.74 Bn | -13.28 | 143.91 | 8.57 Bn |
| 88 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.41 Bn | -50.01 | — | 9.41 Bn |
| 89 | WLK | Westlake Corp | secondary | M-01 | Chemicals | MG-01 | 9.27 Bn | -7.78 | 0.82 | 7.41 Bn |
| 90 | VIAV | Viavi Solutions Inc. | secondary | T-15 | Computer Hardware | TG-02 | 9.04 Bn | -289.60 | 5.95 | 8.39 Bn |
| 91 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 92 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.74 Bn | -56.64 | 17.93 | 7.58 Bn |
| 93 | ICL | ICL Group Ltd. | secondary | M-04 | Chemicals | MG-01 | 7.60 Bn | 23.03 | 0.99 | 6.94 Bn |
| 94 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.59 Bn | 114.81 | 4.55 | 6.94 Bn |
| 95 | SASOF | Sasol Ltd | secondary | E-01 | Oil and Gas Upstream | EG-01 | 7.01 Bn | 9.20 | 0.43 | 4.43 Bn |
| 96 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.43 Bn | -39.46 | 1.21 | 6.05 Bn |
| 97 | INGR | Ingredion Inc | secondary | S-07 | Agribusiness | SG-03 | 6.34 Bn | 10.59 | 0.88 | 5.39 Bn |
| 98 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.30 Bn | -703.30 | 4,524.98 | 6.30 Bn |
| 99 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | 0.08 | — | 6.21 Bn |
| 100 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.18 Bn | -142.29 | 10.46 | 6.07 Bn |
| 101 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.09 Bn | 43.92 | 13.50 | 5.80 Bn |
| 102 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.55 | 31.98 | 5.64 Bn |
| 103 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.52 Bn | 25.65 | 1.77 | 5.39 Bn |
| 104 | MTRN | MATERION Corp | secondary | M-16 | Metals and Mining | MG-02 | 5.32 Bn | 59.04 | 2.54 | 5.30 Bn |
| 105 | PRM | Perimeter Solutions, Inc. | secondary | I-04 | Machinery | IG-02 | 5.15 Bn | -15.15 | 6.80 | 5.06 Bn |
| 106 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.04 Bn | -17.55 | — | 5.04 Bn |
| 107 | CSW | Csw Industrials, Inc. | secondary | I-14 | Construction Products | IG-03 | 4.92 Bn | — | — | 4.89 Bn |
| 108 | CE | Celanese Corp | secondary | M-01 | Chemicals | MG-01 | 4.88 Bn | -4.22 | 0.50 | 3.52 Bn |
| 109 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 110 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.78 Bn | 12.55 | 4.19 | 3.82 Bn |
| 111 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.66 Bn | -23.64 | — | 4.66 Bn |
| 112 | AXTI | Axt Inc | secondary | T-04 | Semiconductors | TG-01 | 4.34 Bn | -2,869.69 | 37.20 | 3.55 Bn |
| 113 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.20 Bn | -11.88 | — | 4.20 Bn |
| 114 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.05 Bn | 11.41 | 3.04 | 3.83 Bn |
| 115 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.02 Bn | -7.86 | 1,115.68 | 4.02 Bn |
| 116 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.01 Bn | -46.57 | — | 4.01 Bn |
| 117 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 118 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | -45.72 | — | 3.85 Bn |
| 119 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.66 Bn | -78.05 | 6.04 | 3.21 Bn |
| 120 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.26 | 0.59 | 2.47 Bn |
| 121 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.58 Bn | -7.79 | 30.62 | 2.88 Bn |
| 122 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.99 Bn | -11.06 | 593.06 | 2.47 Bn |
| 123 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -8.55 | 79.36 | 2.47 Bn |
| 124 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.90 Bn | -11.17 | 407.13 | 2.90 Bn |
| 125 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.03 | 6.29 | 2.12 Bn |
| 126 | FUL | Fuller H B Co | secondary | M-03 | Chemicals | MG-01 | 2.82 Bn | 19.09 | 0.80 | 2.71 Bn |
| 127 | WTTR | Select Water Solutions, Inc. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 2.79 Bn | 86.82 | 1.95 | 2.75 Bn |
| 128 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.72 Bn | -22.95 | 2.08 | 2.63 Bn |
| 129 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -81.01 | — | 2.63 Bn |
| 130 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | -7.51 | — | 2.62 Bn |
| 131 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.56 | 0.06 | -3.18 Bn |
| 132 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | -61.82 | — | 2.61 Bn |
| 133 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 134 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.61 | 3.09 | 2.06 Bn |
| 135 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | 13.64 | 2.53 | 1.63 Bn |
| 136 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -2.18 | 0.22 | 0.55 Bn |
| 137 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.31 Bn | -5.99 | 4.31 | 1.95 Bn |
| 138 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -21.22 | 13.51 | 2.29 Bn |
| 139 | CC | Chemours Co | secondary | M-01 | Chemicals | MG-01 | 2.29 Bn | -7.52 | 0.40 | 1.62 Bn |
| 140 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.25 Bn | -3.84 | — | 1.99 Bn |
| 141 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.19 Bn | -41.35 | — | 1.88 Bn |
| 142 | MTX | Minerals Technologies Inc | secondary | M-16 | Metals and Mining | MG-02 | 2.16 Bn | -7.90 | 1.01 | 1.81 Bn |
| 143 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.67 | 6.73 | 1.65 Bn |
| 144 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.05 Bn | -4.92 | 2,045.15 | 2.05 Bn |
| 145 | OLN | OLIN Corp | secondary | M-01 | Chemicals | MG-01 | 2.02 Bn | -10.26 | 0.30 | 1.84 Bn |
| 146 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | 171.80 | 16.36 | 1.61 Bn |
| 147 | BAK | Braskem Sa | secondary | M-01 | Chemicals | MG-01 | 1.59 Bn | -0.82 | 0.11 | -0.60 Bn |
| 148 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 149 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | 7.84 | 2.99 | 0.96 Bn |
| 150 | PAHC | Phibro Animal Health Corp | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | 15.05 | 0.99 | 1.42 Bn |
| 151 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | 13.88 | 1.53 | 1.14 Bn |
| 152 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -3.23 | 2.08 | 1.20 Bn |
| 153 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -24.09 | — | 1.46 Bn |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.45 Bn | -84.47 | 4.32 | 1.33 Bn |
| 155 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.68 | — | 1.42 Bn |
| 156 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.26 | 5.13 | 1.33 Bn |
| 157 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.63 | 35.82 | 1.38 Bn |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -25.48 | — | 1.00 Bn |
| 159 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.19 Bn | -31.29 | 2.02 | 0.88 Bn |
| 160 | ECVT | Ecovyst Inc. | secondary | M-01 | Chemicals | MG-01 | 1.13 Bn | -18.28 | 1.30 | 1.04 Bn |
| 161 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.11 Bn | -5.42 | — | 1.11 Bn |
| 162 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.97 | 1.08 Bn |
| 163 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 69.00 | 1.35 | 0.76 Bn |
| 164 | ACDC | ProFrac Holding Corp. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 0.98 Bn | -2.38 | 0.55 | 0.96 Bn |
| 165 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -69.78 | — | 0.91 Bn |
| 166 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -15.13 | 22.94 | 0.76 Bn |
| 167 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.76 | — | 0.74 Bn |
| 168 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -48.72 | — | 0.93 Bn |
| 169 | KODK | Eastman Kodak Co | secondary | I-30 | Business Services | IG-06 | 0.89 Bn | -13.47 | 0.78 | 0.57 Bn |
| 170 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.84 Bn | -10.51 | 101.77 | 0.84 Bn |
| 171 | DQ | Daqo New Energy Corp. | secondary | M-01 | Chemicals | MG-01 | 0.81 Bn | -4.22 | 1.46 | 0.00 Bn |
| 172 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.81 Bn | -6.99 | 9.20 | 0.67 Bn |
| 173 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | 16.02 | 0.95 | 0.62 Bn |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | -7.56 | 3.10 | 0.56 Bn |
| 175 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | 12.55 | 5.37 | 0.51 Bn |
| 176 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | -38.37 | 5.93 | 0.65 Bn |
| 177 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 178 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.09 | 1.71 | 0.38 Bn |
| 179 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.18 | 11.83 | 0.54 Bn |
| 180 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -3.07 | — | 0.62 Bn |
| 181 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -344,077.60 | — | 0.60 Bn |
| 182 | LPTH | Lightpath Technologies Inc | secondary | I-02 | Aerospace and Defense | IG-01 | 0.60 Bn | -70.19 | 9.60 | 0.55 Bn |
| 183 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,174.84 | 6.08 | 0.48 Bn |
| 184 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -16.63 | 1.80 | 0.53 Bn |
| 185 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -18.13 | — | 0.55 Bn |
| 186 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.98 | 0.45 Bn |
| 187 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.46 | 336.78 | 0.42 Bn |
| 188 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.37 | 4.48 | 0.38 Bn |
| 189 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -7.58 | 22.77 | 0.23 Bn |
| 190 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.49 Bn | -10.27 | 78.36 | 0.26 Bn |
| 191 | LXFR | Luxfer Holdings Plc | secondary | I-09 | Machinery | IG-02 | 0.46 Bn | 57.82 | 1.27 | 0.45 Bn |
| 192 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.61 | 889.92 | 0.32 Bn |
| 193 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.91 | 27.94 | 0.25 Bn |
| 194 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.46 | — | 0.26 Bn |
| 195 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -53.83 | — | 0.41 Bn |
| 196 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -85.61 | 11.05 | 0.41 Bn |
| 197 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -4.26 | 40.29 | 0.20 Bn |
| 198 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.42 | — | 0.33 Bn |
| 199 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 200 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.46 | 0.15 Bn |
| 201 | NNDM | Nano Dimension Ltd. | secondary | I-12 | Machinery | IG-02 | 0.31 Bn | -2.14 | 2.58 | -0.04 Bn |
| 202 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.76 | 7.48 | 0.27 Bn |
| 203 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.12 | — | 0.30 Bn |
| 204 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.66 | 0.38 | 0.15 Bn |
| 205 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.25 | — | 0.29 Bn |
| 206 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -1.97 | — | 0.28 Bn |
| 207 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.88 | 1.20 | 0.11 Bn |
| 208 | NAGE | Niagen Bioscience, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.24 Bn | 15.18 | 1.88 | 0.18 Bn |
| 209 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.02 | 0.00 | -10.84 Bn |
| 210 | MVST | Microvast Holdings, Inc. | secondary | I-43 | Clean Energy Equipment | IG-10 | 0.23 Bn | -39.38 | 0.61 | 0.08 Bn |
| 211 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 212 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.35 | 7.42 | 0.22 Bn |
| 213 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.09 | — | 0.21 Bn |
| 214 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -57.60 | 3.09 | 0.18 Bn |
| 215 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.78 | — | 0.20 Bn |
| 216 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.30 | 14.98 | 0.16 Bn |
| 217 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -30.08 | — | 0.20 Bn |
| 218 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.47 | 107.94 | 0.15 Bn |
| 219 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -37.45 | 8.18 | 0.19 Bn |
| 220 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -1.52 | — | 0.13 Bn |
| 221 | PLG | Platinum Group Metals Ltd | secondary | M-15 | Metals and Mining | MG-02 | 0.17 Bn | 41.89 | — | 0.17 Bn |
| 222 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 223 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.24 | 7.47 | 0.16 Bn |
| 224 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.42 | 109.36 | 0.15 Bn |
| 225 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 | 1,818.12 | -0.04 Bn |
| 226 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.88 | — | 0.14 Bn |
| 227 | BMEA | Biomea Fusion, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.37 | — | 0.13 Bn |
| 228 | UFI | Unifi Inc | secondary | M-01 | Chemicals | MG-01 | 0.12 Bn | -3.60 | 0.23 | 0.10 Bn |
| 229 | CBUS | Cibus, Inc. | secondary | M-05 | Chemicals | MG-01 | 0.12 Bn | -1.17 | 34.12 | 0.10 Bn |
| 230 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.27 | — | 0.10 Bn |
| 231 | VRCA | Verrica Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.44 | 3.57 | 0.10 Bn |
| 232 | AARD | Aardvark Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.54 | — | 0.03 Bn |
| 233 | CPIX | Cumberland Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.98 | 3.10 | 0.09 Bn |
| 234 | TENX | Tenax Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.48 | — | 0.10 Bn |
| 235 | CGTX | Cognition Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.50 | — | 0.09 Bn |
| 236 | NTHI | Neonc Technologies Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.04 | — | 0.09 Bn |
| 237 | MNOV | Medicinova Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.59 | 99.85 | 0.09 Bn |
| 238 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 2.70 | — | 0.08 Bn |
| 239 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.57 | 0.06 Bn |
| 240 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.00 | 1.21 | -0.11 Bn |
| 241 | VRDR | Verde Resources, Inc. | secondary | I-15 | Construction Services | IG-04 | 0.08 Bn | -21.30 | 165.82 | 0.08 Bn |
| 242 | RGC | Regencell Bioscience Holdings Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.08 Bn |
| 243 | PMVP | PMV Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.21 | — | -0.01 Bn |
| 244 | PLRX | Pliant Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 245 | LNZA | LanzaTech Global, Inc. | secondary | I-37 | Environmental Equipment | IG-09 | 0.07 Bn | -1.22 | 1.26 | 0.02 Bn |
| 246 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.07 Bn | -0.08 | 3.44 | 0.06 Bn |
| 247 | SLSN | Solesence, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.06 Bn | -26.68 | 1.15 | 0.06 Bn |
| 248 | BOLD | Boundless Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 249 | VERU | Veru Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 117.37 | — | 0.03 Bn |
| 250 | FEAM | 5E Advanced Materials, Inc. | secondary | M-16 | Metals and Mining | MG-02 | 0.05 Bn | -1.44 | — | 0.05 Bn |
| 251 | GOSS | Gossamer Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.30 | 0.96 | -0.01 Bn |
| 252 | FTEK | Fuel Tech, Inc. | secondary | I-37 | Environmental Equipment | IG-09 | 0.05 Bn | -14.47 | 1.84 | 0.03 Bn |
| 253 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.83 | 3.81 | 0.05 Bn |
| 254 | KPTI | Karyopharm Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.25 | 0.33 | -0.02 Bn |
| 255 | ANVS | Annovis Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.96 | — | 0.05 Bn |
| 256 | CLNN | Clene Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.34 | 213.14 | 0.04 Bn |
| 257 | APRE | Aprea Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.42 | — | 0.04 Bn |
| 258 | IXHL | Incannex Healthcare Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.85 | — | 0.04 Bn |
| 259 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.72 | 4.79 | 0.03 Bn |
| 260 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.18 | -0.08 Bn |
| 261 | GRCE | Grace Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.85 | — | 0.04 Bn |
| 262 | CPHI | China Pharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.57 | 8.66 | 0.03 Bn |
| 263 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.04 Bn |
| 264 | UG | United Guardian Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.56 | 2.94 | 0.02 Bn |
| 265 | ACTU | Actuate Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.54 | — | 0.03 Bn |
| 266 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -6.19 | 0.38 | 0.03 Bn |
| 267 | NSRX | Nasus Pharma Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 268 | BYSI | BeyondSpring Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.02 | — | 0.03 Bn |
| 269 | BCHT | Birchtech Corp. | secondary | I-37 | Environmental Equipment | IG-09 | 0.03 Bn | -7.32 | 1.33 | 0.01 Bn |
| 270 | CRVO | CervoMed Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.84 | 76.69 | 0.03 Bn |
| 271 | TXMD | TherapeuticsMD, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -135.76 | 7.68 | 0.02 Bn |
| 272 | RDGL | Vivos Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -8.86 | 399.68 | 0.02 Bn |
| 273 | YARW | Yarrow Bioscience, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.12 | 46.85 | 0.00 Bn |
| 274 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.75 | 0.40 | 0.00 Bn |
| 275 | ATOS | Atossa Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.72 | — | 0.02 Bn |
| 276 | ALLR | Allarity Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.68 | 814.63 | 0.02 Bn |
| 277 | BFRI | Biofrontera Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.31 | 0.45 | 0.02 Bn |
| 278 | MIRA | Mira Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.56 | — | 0.01 Bn |
| 279 | DYAI | Dyadic International Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.59 | 4.86 | 0.01 Bn |
| 280 | PMEC | Primech Holdings Ltd | secondary | I-27 | Business Services | IG-06 | 0.02 Bn | -6.11 | 0.22 | 0.01 Bn |
| 281 | TVRD | Tvardi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.68 | — | 0.02 Bn |
| 282 | KPRX | Kiora Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.42 | — | 0.02 Bn |
| 283 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.02 Bn | -1.26 | — | 0.01 Bn |
| 284 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.18 | 0.02 Bn |
| 285 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.01 Bn | -2.05 | — | 0.01 Bn |
| 286 | ANEB | Anebulo Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 287 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.04 | — | 0.01 Bn |
| 288 | NAII | Natural Alternatives International Inc | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | -0.86 | 0.09 | 0.00 Bn |
| 289 | INTI | Inhibitor Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 290 | CALC | CalciMedica, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.32 | -8.02 | -0.01 Bn |
| 291 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.74 | — | 0.01 Bn |
| 292 | CURX | Curanex Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.88 | — | 0.00 Bn |
| 293 | ADXN | Addex Therapeutics Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 294 | ACXP | Acurx Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 295 | PULM | Pulmatrix, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.46 | — | 0.01 Bn |
| 296 | TRAW | Traws Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.34 | — | 0.00 Bn |
| 297 | PCSA | Processa Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.41 | — | 0.01 Bn |
| 298 | GURE | Gulf Resources, Inc. | secondary | M-01 | Chemicals | MG-01 | 0.01 Bn | -0.12 | 0.20 | 0.00 Bn |
| 299 | TPST | Tempest Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.25 | — | 0.00 Bn |
| 300 | TCRT | Alaunos Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.94 | 1,276.64 | 0.00 Bn |